• Media
    • Press Releases
    • Events & Presentations
  • Contact
  • Careers
  • About Us
  • Science
  • Patients
    • Patients
    • COVID-19
    • Lymphoma
    • Lung Cancer (NSCLC)
    • Lupus (SLE)
  • Physicians
  • Pipeline
    • Pipeline
    • Olgotrelvir
    • Abivertinib
    • AC0058
    • STI-6129
    • AC0939 (STI-8591)
    • AC-PRO
    • STI-1492
  • Investors
  • Media
    • Press Releases
    • Events & Presentations
  • Contact
  • Careers

Learn about our Product Candidates

Olgotrelvir
Learn More
Abivertinib
Learn More
AC0058
Learn More
STI-6129
Learn More
AC0939
Learn More
AC-PRO
Learn More
STI-1492
Learn More
  • About Us
  • Science
  • Patients
  • Physicians
  • Pipeline
  • Investors
  • Media
  • Contact
  • Careers
© 2025 ACEA Therapeutics | All Rights Reserved. | Terms of Use | Privacy Policy
  • About Us
  • Science
  • Patients
    • Patients
    • COVID-19
    • Lymphoma
    • Lung Cancer (NSCLC)
    • Lupus (SLE)
  • Physicians
  • Pipeline
    • Pipeline
    • Olgotrelvir
    • Abivertinib
    • AC0058
    • STI-6129
    • AC0939 (STI-8591)
    • AC-PRO
    • STI-1492
  • Investors
  • Media
    • Press Releases
    • Events & Presentations
  • Contact
  • Careers